Methods Of Using Interleukin-10 For Treating Diseases And Disorders

Patent No. EP3341012 (titled "Methods Of Using Interleukin-10 For Treating Diseases And Disorders") was filed by Armo Biosciences on Aug 24, 2016. The application was issued on Jul 30, 2025.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Aug 12, 2025
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 3, 2025
Decision to grant a European patent
Jun 20, 2025
(Electronic) Receipt
Jun 20, 2025
Filing of the translations of the claims
Jun 20, 2025
French translation of claims
Jun 20, 2025
German translation of the claims
Jun 20, 2025
Letter accompanying subsequently filed items
Feb 21, 2025
Annex to the communication about intention to grant a European patent
Feb 21, 2025
Bibliographic data of the European patent application
Feb 21, 2025
Communication about intention to grant a European patent
Feb 21, 2025
Intention to grant (signatures)
Feb 21, 2025
Text intended for grant (clean copy)
Feb 21, 2025
Text intended for grant (version for approval)
Aug 1, 2024
(Electronic) Receipt
Aug 1, 2024
Letter accompanying subsequently filed items
Aug 1, 2024
Letter concerning fees and payments
Jun 7, 2024
(Electronic) Receipt
Jun 7, 2024
Amended claims with annotations
Jun 7, 2024
Amended description with annotations
Jun 7, 2024
Claims
Jun 7, 2024
Description
Jun 7, 2024
Letter accompanying subsequently filed items
Jun 7, 2024
Reply to communication from the Examining Division
Feb 9, 2024
Annex to the communication
Feb 9, 2024
Consultation by telephone/in person (with time limit)
Feb 9, 2024
Result of consultation by telephone/in person
Aug 17, 2023
(Electronic) Receipt
Aug 17, 2023
Letter accompanying subsequently filed items
Aug 17, 2023
Letter concerning fees and payments
Mar 21, 2023
(Electronic) Receipt
Mar 21, 2023
Amended claims with annotations
Mar 21, 2023
Claims
Mar 21, 2023
Letter accompanying subsequently filed items
Mar 21, 2023
Reply to communication from the Examining Division
Jan 18, 2023
Grant of extension of time limit (examination procedure)
Jan 12, 2023
(Electronic) Receipt
Jan 12, 2023
Letter accompanying subsequently filed items
Jan 12, 2023
Request for extension of time limit to communication from the Examining Division
Sep 14, 2022
Annex to the communication
Sep 14, 2022
Communication from the Examining Division
Sep 9, 2022
Examination started
Aug 1, 2022
(Electronic) Receipt
Aug 1, 2022
Letter accompanying subsequently filed items
Aug 1, 2022
Letter concerning fees and payments
Sep 20, 2021
Document concerning representation
Aug 4, 2021
(Electronic) Receipt
Aug 4, 2021
Letter concerning fees and payments
Aug 4, 2021
Letter concerning fees and payments
Mar 31, 2021
Communication of amended entries concerning the representative
Mar 30, 2021
Confirmation of revocation of automatic debit order
Mar 25, 2021
(Electronic) Receipt
Mar 25, 2021
Letter accompanying subsequently filed items
Mar 25, 2021
Letter relating to the automatic debiting procedure
Mar 25, 2021
Submission concerning change of applicant's representative
Mar 25, 2021
Submission concerning representation
Dec 1, 2020
Document concerning representation
Sep 13, 2019
(Electronic) Receipt
Sep 13, 2019
Amended claims filed after receipt of (European) search report
Sep 13, 2019
Amended claims with annotations
Sep 13, 2019
Amendments received before examination
Sep 13, 2019
Letter accompanying subsequently filed items
Mar 5, 2019
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Feb 15, 2019
Communication regarding the transmission of the European search report
Feb 15, 2019
European search opinion
Feb 15, 2019
Information on Search Strategy
Feb 15, 2019
Supplementary European search report
Jan 31, 2019
Search started
Oct 12, 2018
(Electronic) Receipt
Oct 12, 2018
Amended claims filed after receipt of (European) search report
Oct 12, 2018
Amendments received before examination
Oct 12, 2018
Letter accompanying subsequently filed items
Aug 29, 2018
Refund of fees
Aug 17, 2018
Letter relating to the automatic debiting procedure
Aug 3, 2018
Communication confirming withdrawal from representation
Aug 3, 2018
Communication of amended entries concerning the representative
Jul 31, 2018
(Electronic) Receipt
Jul 31, 2018
Letter accompanying subsequently filed items
Jul 31, 2018
Submission concerning change of applicant's representative
Jun 6, 2018
Notification on forthcoming publication of bibliographic data
Apr 5, 2018
Communication regarding possible amendment of the application/payment of claims fee
Apr 3, 2018
Communication to designated inventor
Apr 3, 2018
Communication to designated inventor
Mar 12, 2018
Copy of the international preliminary report on patentability
Feb 28, 2018
(Electronic) Receipt
Feb 28, 2018
Converted Sequence Listing
Feb 28, 2018
Request for entry into the European phase
Feb 28, 2018
Submission concerning representation
Jan 5, 2018
Information on entry into European phase
Mar 23, 2017
Priority document (electronically transmitted)
Mar 2, 2017
Converted Sequence Listing
Mar 2, 2017
Copy of the international search report
Mar 2, 2017
Published international application - A1

EP3341012

ARMO BIOSCIENCES

Application Number: EP16840035A
Filing Date: Aug 24, 2016
Status: Granted And Under Opposition; Jun 27, 2025
Publication Date: Jul 30, 2025
External Links: Slate, Register , Google Patents

IP Verse

Methods Of Using Interleukin-10 For Treating Diseases And Disorders

Patent Summary

Patent Family

Dossier Documents

EP3341012